Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Share Price Hits 52-Week High
- July 31, 2026
- Posted by: Harsh Piplani
- Category: News
Sun Pharmaceutical Industries Ltd. Share Price reached a fresh 52-week high of Rs 2,021, with a current price of Rs 2,013.2, marking a 0.62% increase today. The market cap stands at Rs 4,77,407.68 crore.
Sun Pharmaceutical Industries Ltd. Share Price has reached a new 52-week high of Rs 2,021, with the current price at Rs 2,013.2, reflecting a 0.62% increase from the previous close of Rs 2,000.75. This milestone highlights the stock’s strong performance in the market, with a significant market capitalisation of Rs 4,77,407.68 crore. Investors are closely monitoring SUNPHARMA’s movements as it continues to gain traction in the healthcare sector.
Sun Pharmaceutical Industries Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,013.2 |
| Previous Close | Rs 2,000.75 |
| Today's Change | +Rs 12.45 (+0.62%) |
| Day Open | Rs 2,019.8 |
| Fresh 52-Week High | Rs 2,021 |
| Day Low | Rs 2,005 |
| Current Volume | 4,731 |
| Turnover | Rs 0.95 crore |
| Market Capitalisation | Rs 4,77,407.68 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) traded at Rs 2,013.2. versus the previous close of Rs 2,000.75, a rise of 0.62%. The stock opened at Rs 2,019.8, reached Rs 2,021, touched Rs 2,005. Reported volume was 4,731.
Today, Sun Pharmaceutical Industries Ltd. opened at Rs 2,019.8 and reached a high of Rs 2,021, marking a fresh 52-week high. The stock closed at Rs 2,013.2, up by Rs 12.45 or 0.62% from the previous close of Rs 2,000.75. The day’s low was Rs 2,005, with a turnover of Rs 0.95 crore and a volume of 4,731 shares. This price action indicates a positive sentiment among investors, driving the stock to new heights.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,77,407.68 crore |
| P/E Ratio | 39.17x |
| P/B Ratio | 7.93x |
| ROE | 28.21% |
| ROCE | 26.35% |
Sun Pharmaceutical Industries Ltd. was valued at a P/E ratio of 39.17x, a P/B ratio of 7.93x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 39.17x |
| Benchmark Median P/E | 20.13x |
| Benchmark Average P/E | 73.73x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 7.93x |
| Benchmark Median P/B | 1.92x |
| Company ROE | 28.21% |
| Benchmark Median ROE | 10.73% |
| Company ROCE | 26.35% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 4,77,407.68 crore |
| Benchmark Median Market Cap | Rs 140.91 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) is classified under sector: Healthcare.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 39.17x, which is above the benchmark median of 20.13x, a difference of +94.59%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROE of 28.21%, which is above the benchmark median of 10.73%, a difference of +162.91%. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROCE of 26.35%, which is above the benchmark median of 13.2%, a difference of +99.62%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd. | KPL | 2,700.98 | 39.17 | 7.93 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,475.7 | 58.88 | 9.32 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,439.14 | 165.82 | 3.06 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,424.44 | 34.59 | 7 | -2.6 | 16.92 |
| Venus Remedies Ltd. | VENUSREM-BE | 2,150.28 | 17.79 | 3.01 | 9.85 | 7.89 |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 39.17x compared with the displayed peer median of 39.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a market capitalisation of Rs 4,77,407.68 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Sun Pharmaceutical Industries Ltd.
- Fresh 52-week high of Rs 2,021 achieved.
- Strong market capitalisation of Rs 4,77,407.68 crore.
- High P/E and P/B ratios compared to sector medians.
- Superior ROE and ROCE indicating strong profitability.
- Leading position in the healthcare sector.
About Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is a leading pharmaceutical company in India, engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company operates in the healthcare sector, offering a wide range of products across various therapeutic segments. With a strong market presence and a commitment to innovation, Sun Pharma continues to expand its global footprint, catering to diverse healthcare needs.
Track Sun Pharmaceutical Industries Ltd. Share Price on Univest
Use Sun Pharmaceutical Industries Ltd. (SUNPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track the live share price of Sun Pharmaceutical Industries Ltd., along with technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest. Stay informed with the latest data and analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Sun Pharmaceutical Industries Ltd.?
Ans. The current share price of Sun Pharmaceutical Industries Ltd. is Rs 2,013.2, reflecting a 0.62% increase from the previous close of Rs 2,000.75. The stock moved 0.62% during the session.
What was the 52-week high for Sun Pharmaceutical Industries Ltd.?
Ans. The 52-week high for Sun Pharmaceutical Industries Ltd. was Rs 2,021, achieved today, marking a significant milestone for the stock. The stock moved 0.62% during the session. The intraday range extended from Rs 2,005 to Rs 2,021.
How does Sun Pharma's P/E ratio compare to the sector median?
Ans. Sun Pharma's P/E ratio of 39.17 is higher than the healthcare sector median of 20.13, indicating a relatively expensive valuation. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.
What is Sun Pharmaceutical Industries Ltd.'s market capitalisation?
Ans. Sun Pharmaceutical Industries Ltd.'s market capitalisation is Rs 4,77,407.68 crore, making it a major player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 39.17x.
How does Sun Pharma's ROE compare to its peers?
Ans. Sun Pharma's ROE of 28.21% is among the highest in its peer group, indicating strong profitability and operational efficiency. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.
What is the P/B ratio of Sun Pharmaceutical Industries Ltd.?
Ans. The P/B ratio of Sun Pharmaceutical Industries Ltd. is 7.93, which is significantly higher than the sector median of 1.92. The company trades at a P/E ratio of 39.17x. Its P/B ratio is 7.93x.
Who are Sun Pharma's main competitors?
Ans. Sun Pharma's main competitors include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., and Sai Parenteral's Ltd., among others in the healthcare sector. Comparable listed companies include Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd.
What is the ROCE of Sun Pharmaceutical Industries Ltd.?
Ans. The ROCE of Sun Pharmaceutical Industries Ltd. is 26.35%, indicating strong returns on capital employed compared to sector peers. ROE stands at 28.21%. ROCE stands at 26.35%. The relevant peer median ROE is 10.73%.
How does Sun Pharma's market cap compare to its peers?
Ans. Sun Pharma's market cap of Rs 4,77,407.68 crore is significantly larger than its peers, such as Kwality Pharmaceuticals Ltd. and Beta Drugs Ltd. The company operates in the Healthcare sector.
